PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

May 2003 (Vol:2003, Issue: 36)

Next Issue >>

Download pdf of entire issue

Section: Company Profile
Leo Pharma A/S Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Novo Nordisk and Fournier Pharma Sign Co-Marketing Agreement for Repaglinide in Europe Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Eyetech Pharmaceuticals Enters Deal to Market Pfizer’s Xalatan® Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Section: General
Shire and Noven in ADHD Deal Published: 3 May-2003
By: Business Review Editor
Abstract
Celltech, Oxford GlycoSciences and the Bidding War That Never Was Published: 3 May-2003
By: Business Review Editor
Abstract
Therapy Focus: Psoriasis Published: 3 May-2003
By: Business Review Editor
Abstract
Section: Licensing
Guilford Licenses Neurological Drugs to Pfizer Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
GSK and Neose in Vaccine Deal Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Quintiles moves from Public to Private via cash Merger Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Schering and Astex Enter Multi-target Drug Discovery Alliance Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:
Allergen and Acadia Enter Third Drug Discovery Collaboration Published: 3 May-2003
By: Business Review Editor
Abstract Fulltext:

Bookmark PharmaDeals through one of these social networks.

Table of Contents